Research led by the Department of General and Visceral Surgery, Faculty of Medicine, University of Freiburg, Germany has ...

Heart disease was once considered a concern mainly for older adults, but that’s no longer the case. Across India, more young ...

Restaurants will reportedly be forced to tell the Government what their customers eat under new plans. Ministers are thought ...

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

Due to popularity of the medications, GLP-1s were in short supply up until recently. Obesity is a common issue among ...

The projections come as National Cancer Institute data notes an increase in uterine cancer cases and deaths over the past 30 ...

Supermarkets could be fined if they fail to hit new healthy eating targets - The ‘Healthy Food Standard’ will apply to major ...

Large restaurant and fast food chains will soon be required to tell the Government how many calories their customers consume on average as part of a broader plan to improve the nation’s health.

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

MET-097 is a glucagon-like peptide 1 receptor (GLP-1R) agonist developed at Metsera for treating overweight and obesity and is currently in phase II clinical trials.

The number of people receiving the enhanced mobility personal independence payments (PIP) has shot up from 734,136 in January ...

Scientists from Western University have discovered that a natural compound found in sweet oranges and tangerines, called ...